Cancer Screening Costs Over $43 Billion a Year in the U.S., Study Estimates Colorectal cancer screening accounted for 64% of the total amount Aug 05, 2024
PSMA PET Beats MRI in Prostate Cancer Staging Study Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors Jul 02, 2024
What's a Normal PSA Value for Transgender Women on Estrogen Therapy? Study suggests threshold is too high to identify risk of prostate cancer in this population Jun 26, 2024
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers Jun 13, 2024
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Shows Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
Metformin Fails to Stop Early Prostate Cancer Progression Study suggests it may even be detrimental in some groups of patients on active surveillance Jun 05, 2024
Cheap Drug Eases Hot Flashes in Men With Prostate Cancer Anticholinergic oxybutynin for patients taking ADT also improved quality of life in the process Jun 03, 2024
More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer Half of patients did not have grade reclassification or treatment after 10 years of follow-up May 30, 2024
Psychostimulant No Help in Relieving Cancer-Related Fatigue No significant differences in outcomes between methylphenidate, placebo May 22, 2024
PSA Nadir 6 Months After Primary RT Correlates With Prostate Cancer Outcomes Or does it? Editorial questions prognostic, predictive value in contemporary practice May 22, 2024
Lack of Clinical Trial Availability Tied to Worse Prostate Cancer Mortality "It's a trend we really don't want to see," researcher says May 06, 2024
No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomy Biochemical control maintained despite high rates of testosterone recovery May 05, 2024
HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer Better urinary and erectile function outcomes with high-intensity focused ultrasound May 04, 2024
Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy Risk for any second malignancy, death from any second malignancy not higher versus prostatectomy Apr 23, 2024
Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT No difference in freedom from distant metastasis or overall survival at 10 years Apr 19, 2024
Urine Test Accurately Detected High-Grade Prostate Cancer Researchers say use of the test could substantially reduce unnecessary biopsies Apr 18, 2024
Could Francis Collins's Prostate Cancer Story Deter Men From Active Surveillance? Experts suggest his apparent situation is rare Apr 17, 2024
Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis Former NIH director said he went public to "share lifesaving information" Apr 12, 2024
Novel PARP1 Inhibitor Shows Promise in Breast Cancer The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening Early results suggest approach reduces overdiagnosis while better detecting high-grade cancer Apr 06, 2024
Bracing for a Surge in Prostate Cancer Diagnoses Report: Demographic changes will lead to a doubling of cases, 85% increase in mortality by 2040 Apr 05, 2024
Some Cancer Patients Can Find It Hard to Tell Family and Friends Recent high-profile examples highlight this reluctance Mar 31, 2024
Mutation Linked to Increased Risk of Prostate Cancer Mortality Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele Mar 20, 2024
Study Tests Office-Based Transperineal Approach to Prostate Biopsies Antibiotic-free option resulted in zero infections in randomized trial Feb 29, 2024 video
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD Feb 22, 2024 video
Radioligand Therapy Continues to Show Promise for Metastatic CRPC Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients Feb 16, 2024
More Data Support Olaparib-Abiraterone in BRCA-Mutant Prostate Cancer BRCAAway trial confirms role of combination in first-line setting Feb 15, 2024 video
Improved Fitness May Reduce Prostate Cancer Risk Observational study finds reduced incidence in men who increased their cardiorespiratory fitness Feb 01, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone Jan 29, 2024
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity Jan 28, 2024
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC Combination improved PFS versus more hormonal therapy, but control arm questioned Jan 26, 2024
Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone In small first-line trial, PFS more than doubled with combination Jan 26, 2024
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer Intensification should be considered for high-risk patients, researchers say Jan 24, 2024
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet But opening up can help reduce stigma and inform the public Jan 18, 2024
Surgeon Dies in Plane Crash; Austin Released From Hospital; Animal Pandemic Spreads Health news and commentary from around the Web gathered by 鶹ý staff Jan 16, 2024
